The exosomal miRNA/FOXN3 axis empowers fibroblasts with tumor-promoting functions via enhanced migration and altered secretome
Open Access
- 5 June 2026
- journal article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Abstract
Malignant tumor tissues with high proliferative activity are frequently characterized by a rich abundance of cancer-associated fibroblasts (CAFs). Nevertheless, the precise molecular mechanisms by which CAF-tumor cell crosstalk drives malignant proliferation remain incompletely elucidated. In this study, we demonstrate that exosomal microRNAs derived from lung adenocarcinoma cells reprogram adjacent normal fibroblasts into CAFs through downregulation of their common target, FOXN3. Suppression of this transcriptional repressor enhances the expression of genes associated with cell migration and extracellular matrix remodeling, thereby potentiating CAF infiltration into the tumor core. The consequent spatial proximity between CAFs and tumor cells enables the aberrantly altered secretome of CAFs to exert robust paracrine effects on malignancy. By focusing on receptors that interact with these dysregulated secreted proteins, we evaluated the drug sensitivity of patients bearing highly proliferative tumors to receptor-targeting agents, revealing potential therapeutic opportunities. Collectively, our work offers a detailed molecular dissection of tumor cell proliferation and proposes translationally relevant strategies for cancer therapy.Keywords
Funding Information
- the Open Project Program of the State Key Laboratory of Medical Proteomics (SKLP-O202202)
- The Science & Technology Development Fund of Tianjin Education Commission for Higher Education (2021KJ202)
- the Tianjin Key Medical Discipline Construction Project (TJYXZDXK-3-003A)
- The Strategic Priority Research Program of Chinese Academy of Sciences (XDA0460202)
- the Beijing Municipal Natural Science Foundation (Z210011)
- Noncommunicable Chronic Diseases-National Science and Technology Major Project (2025ZD0552004)
This publication has 86 references indexed in Scilit:
- Gene therapy with AAV9‐ SGPL1 in an animal model of lung fibrosisThe Journal of Pathology, 2024
- Non-muscle myosin II isoforms orchestrate substrate stiffness sensing to promote cancer cell contractility and migrationCancer Letters, 2022
- Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalkJournal of Extracellular Vesicles, 2021
- Secretome of Activated Fibroblasts Induced by Exosomes for the Discovery of Biomarkers in Non‐Small Cell Lung CancerSmall, 2020
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic ResistanceCancer Cell, 2019
- Down‐regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasionJournal of Cellular Biochemistry, 2017
- Isolation of a new cell population in the glioblastoma microenvironmentJournal of Neuro-Oncology, 2011
- Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor GrowthCancer Cell, 2011
- Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 SecretionCell, 2005
- Forkhead Transcription Factors: Key Players in Development and MetabolismDevelopmental Biology, 2002